Safety and Efficacy of Intra-arterial Tenecteplase for Noncomplete Reperfusion of Intracranial Occlusions

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 156 participants.

Also called NCT05499832

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 156 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05499832
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Austria, Belgium, Finland, Germany, Netherlands, Portugal, Switzerland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05499832. Randomized; single masking; primary purpose treatment. Start 2023-03-21 (actual); primary completion 2025-10-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Efficacy of Intra-arterial Tenecteplase for Noncomplete Reperfusion of Intracranial Occlusions
Acronym
TECNO
Intervention (Drug)
Tenecteplase
Lead sponsor
Insel Gruppe AG, University Hospital Bern (class: other)

Record details

Record id
cardio:ct-nct05499832
Content hash
23685726931af865a04fc5efcb6234b6594d9a371e84f100435536d8fee4b3cf